Economic implications of hepatic arterial infusion versus intravenous chemotherapy or symptom palliation in the treatment of nonresectable colorectal liver metastases. Meta-Analysis Group In Cancer.
Durand-Zaleski
I
I
Santé Publique, Hôpital Henri Mondor, Créteil, France. isabelle.durand-zaleski@hmn.ap-hop-paris.fr
Roche
B
B
Buyse
M
M
Carlson
R
R
O'Connell
M
M
Rougier
P
P
Chang
A E
AE
Sondak
V K
VK
Kemeny
M
M
Allen-Mersh
T
T
Fagniez
P L
PL
Le Bourgeois
J P
JP
Piedbois
P
P
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000191:economics* / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000473:pathology / Q000628:therapy; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D005602:France; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000191:economics*; D007262:Infusions, Intravenous / Q000191:economics*; D008113:Liver Neoplasms / Q000191:economics / Q000556:secondary / Q000628:therapy*; D015201:Meta-Analysis as Topic; D010166:Palliative Care / Q000191:economics*; D016019:Survival Analysis
D000970:Antineoplastic Agents